Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oncternal Therapeutics Inc (NQ: ONCT )

0.7474 -0.0026 (-0.35%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 161,800
Open 0.7500
Bid (Size) 0.7007 (20)
Ask (Size) 0.7200 (1)
Prev. Close 0.7500
Today's Range 0.7300 - 0.8000
52wk Range 0.6200 - 13.14
Shares Outstanding 58,711,451
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Gold Down Over 3%; Rigetti Computing Shares Spike Higher
Via Benzinga

Performance

YTD
-93.25%
-93.25%
1 Month
-47.92%
-47.92%
3 Month
-82.08%
-82.08%
6 Month
-91.80%
-91.80%
1 Year
-89.35%
-89.35%

More News

Read More
Crude Oil Down 3%; Chicago Fed National Activity Index Falls In October
Via Benzinga
Topics Economy
Exposures Fossil Fuels Interest Rates
Dow Surges Over 300 Points; Bath & Body Works Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Recap: Oncternal Therapeutics Q4 Earnings
Via Benzinga
Oncternal Therapeutics's Earnings: A Preview
Via Benzinga
Dow Surges Over 100 Points; ModivCare Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Surges 3%; Kroger Posts Upbeat Earnings
Via Benzinga
Exposures Fossil Fuels
US Stocks Mixed; Producer Prices Increase In August
Via Benzinga
ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Insiders Buying Westlake Chemical Partners And 2 Other Stocks
Via Benzinga
ONCT Stock Earnings: Oncternal Therapeutics Misses EPS, Beats Revenue for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
American Airlines To Rally Around 32%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Top 5 Health Care Stocks That May Crash This Month
Via Benzinga
Earnings Scheduled For March 7, 2024
Via Benzinga
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Crude Oil Rises Over 3%; US Home Prices Increase In October
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Oncternal Therapeutics Reports Patient Death In Mid-Stage Blood Cancer Study Treated With Second Dose Level
Via Benzinga
Dow Gains Over 50 Points; Chicago Fed National Activity Index Increases For November
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.